baht or 6. 56 percent from the previous year, mainly due to a decrease of drug and medical supply cost since the volume of general patients and social security patients decreased. Besides, the Company
system of new medicines according to the additional standards SET forth by the Food and Drug administration. Therefore, it is necessary to use the capital to proceed the project amount 32,000,000 baht
model in automotive segment. Property, plant and equipment increased by Baht 54.72 million which were new machines that ordered since last year but delayed shipment until the early of this year, and some
last year but the shipment delayed until the early of this year and were the investment for machine and equipment improvement. As of 30 September 2017 the Company had consolidated liabilities increased
Constructions (2) Registration of 100 drugs formulas (54 formulas for human medicine and 46 formulas for animals) owned by the seller (3) Registration of special drug formulas, consisting of 12 formulas including
orders by significantly concern customer safety. The Company still provides necessary services for such as supermarket, convenience stores, banks, drug stores, food and beverages shops for take away and
. 22 Million, not to mention the fact that the Company has a policy on sales of products by requiring certain customers to place deposits before production and pay the remaining balance upon delivery of
products by requiring certain customers to place deposits before production and pay the remaining balance upon delivery of the products. In addition, in case of emergency, the Company is still capable of
positively. On the variable cost side, apart from normal inflation, as highlighted since Q2 fuel prices have increased versus the same period in 2017. The latest fuel shipment in December was more economical
persons ) and related services i.e. registration with Food and Drug Administration (FDA), trademark permission, product and packaging design, and brand building etc. to customers who are business operator